Ipamorelin Peptide
Out of Stock- CAS
- 170851-70-4
- Molecular weight
- 711.9 g/mol
- Form
- Lyophilized powder
- Purity (HPLC)
- COA pending
- Storage
- -20°C or colder
- Lot / COA
- Pending
- Free shippingOn every order
- Free 2nd Day AirOn orders $200+
Research Use Only
For laboratory research use only. Not for human consumption. All products are intended solely for laboratory research and are not for human or animal consumption. By purchasing, the buyer agrees to use these products in compliance with all applicable laws.
Specifications
- CAS
- 170851-70-4
- Molecular formula
- C38H49N9O5
- Molecular weight
- 711.9 g/mol
- Form
- Lyophilized powder
- Purity (HPLC)
- COA pending
- Storage
- -20°C or colder
- Lot / COA
- Pending
- PubChem CID
- 9831659
Ipamorelin Peptide Overview
Ipamorelin is a synthetic pentapeptide and selective secretagogue-type agonist. The Ipamorelin peptide is studied in preclinical and experimental research for its selective pituitary signaling activity with minimal off-target pathway interference. This selectivity makes it an important tool for investigating endocrine signaling, somatotroph axis modulation, and related molecular pathways.
Related research materials in the Medicina Labs catalog include the GHRH analog CJC-1295 (No DAC), the CJC-1295 (No DAC) + Ipamorelin blend, and the secretagogue peptide GHRP-2.
History
Ipamorelin was developed in the 1990s during research into secretagogue-type peptides. Unlike earlier compounds such as GHRP-6, Ipamorelin demonstrated greater selectivity, activating target pathway signaling with minimal off-target interference. Since its discovery, it has been applied in studies investigating pituitary signaling, endocrine cascades, and downstream pathway dynamics in laboratory models.
Ipamorelin Structure
CAS #: 170851-70-4
Molecular Formula: C38H49N9O5
Molecular Weight: 711.9 g/mol
PubChem ID: 9831659
Research Findings
Ipamorelin has been studied in endocrine, receptor-pharmacology, and pituitary signaling models, with research highlighting its agonist activity at the growth hormone secretagogue receptor (GHS-R1a), growth hormone release in pituitary cell and animal models, and downstream IGF-1 pathway signaling. Studies have also compared its selectivity profile with earlier secretagogues such as GHRP-6 and GHRP-2, including its limited effect on ACTH and cortisol release in preclinical systems.
Key Areas of Research:
- Endocrine: Somatotroph axis, signaling, cascades
- Signaling: Systemic markers, pathway dynamics
- Molecular: Remodeling, proliferation, viability
Together, these findings suggest experimental utility for Ipamorelin across multiple biological pathways. By engaging the GHS-R1a receptor with a narrow endocrine selectivity profile, Ipamorelin provides a versatile platform for research into secretagogue receptor pharmacology, pathway dynamics, and endocrine activity in laboratory settings.
Our Process
Precision Lyophilization
Each batch is freeze-dried and sealed for stability until reconstitution.
Verified Purity
Every batch is third-party tested with HPLC and mass spectrometry.
Careful Fulfillment
Orders ship within 24 hours from our U.S. facility.